5.2 Principles of Hormonal Regulations
5.2 Principles of Hormonal Regulations
5.2 Principles of Hormonal Regulations
Regulation
Principles of hormonal regulation
Hormones are substances which can change
the status, function, metabolism and structure
of body organs and tissues.
Morphogenic
Kinetic
Corrective
Hormones classification
Biochemical classification:
1. Steroids
2. Amino-acid derivatives
3. Protein-peptide compounds
Functional classification:
1. Effectory
2. Tropic
3. Neuroregulatory (liberins & statins)
SEQUENCE OF EVENTS INVOLVING CYCLIC
AMP AS A SECOND MESSENGER
Inhibits
sensitivity to
releasing
hormones
Thyroid gland hormones’ effects
Increase metabolism by activating enzymes &
increasing oxygen consumption
As the result increase heat production and
body temperature
Morphogenic influence (especially CNS &
bone tissue)
Activate protein synthesis by increasing
membrane permeability for amino acids
Activate lipids breakdown
Thyroid gland hormones’ effects
Increase glucose level in blood plasma by intensifying
glucose absorbtion in the intestines
Activate gluconeogenesis and glucogenolysis
Inactivate insuline by activation of liver insulinase
Increase heart rate and cardiac output by increasing
adrenoreceptors sensitivity to adrenalin and
increasing the number of receptors
Activate erythropoesis
Regulation of
hormone
secretion by
the regulated
parameter
Disease States
Both increased and decreased secretion of parathyroid hormone are
recognized as causes of serious disease in man and animals.
Excessive secretion of parathyroid hormone is seen in two forms:
Primary hyperparathyroidism is the result of parathyroid gland disease,
most commonly due to a parathyroid tumor (adenoma) which secretes the
hormone without proper regulation. Common manifestations of this
disorder are chronic elevations of blood calcium concentration
(hypercalcemia), kidney stones and decalcification of bone.
Secondary hyperparathyroidism is the situation where disease outside
of the parathyroid gland leads to excessive secretion of parathyroid
hormone. A common cause of this disorder is kidney disease - if the
kidneys are unable to reabsorb calcium, blood calcium levels will fall,
stimulating continual secretion of parathyroid hormone to maintain normal
calcium levels in blood. Secondary hyperparathyroidism can also result
from inadequate nutrition - for example, diets that are deficient in calcium
or vitamin D, or which contain excessive phosphorus (e.g. all meat diets
for carnivores). A prominent effect of secondary hyperparathyroidism is
decalcification of bone, leading to pathologic fractures or "rubber bones".
There is no doubt that chronic secretion or continuous
infusion of parathyroid hormone leads to decalcification of
bone and loss of bone mass. However, in certain
situations, treatment with parathyroid hormone can actually
stimulate an increase in bone mass and bone strength.
This seemingly paradoxical effect occurs when the
hormone is administered in pulses (e.g. by once daily
injection), and such treatment appears to be an effective
therapy for diseases such as osteoporosis.
Functions:
enhances the glycogen splitting in liver;
activates the lipolisis;
stimulates the gluconeogenesis.
Somatostatine.
Somatostatine is produced by hypothalamus, intestine and -cells
of pancreas).
Functions:
inhibits the secretion of insulin and glucagon;
inhibits secretion of somatotropic and thyrotropic hormones;
inhibits secretion of tissue hormones of alimentary tract.
Lipocain.
Lipocain is produced in the epithelium cells of pancreatic ducts.
Functions:
activates the formation of phospholipids in liver and stimulates
the action of lipotropic alimentary factors;
activates the oxidation of fatty acids in liver.
Typical findings in Cushing’s
syndrome
Caused by prolonged decrease in plasma
corticoids
Increased protein catabolism results in :
Thin skin
Poor muscle development
Poor wound healing
Bruisability with ecchymoses
Thin and scraggy hair
Typical findings in Cushing’s
syndrome
Redistribution of body fat : thin extremities, fat
collects in the abdominal wall, face, upper
back
Purple striae (subdermal tissue rapture due to
increased subcutaneous fat depots)
osteoporosis